MedTrace Logo

The Ageing in a Networked Society -Social Experiment Study

NCT04242628 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2022-04-29

No results posted yet for this study

Summary

The Ageing in a Networked Society -Social Experiment study (ANS-SE) is a randomised controlled trial on older people residing in Abbiategrasso, a middle-size city located in the Milan area (Italy) and aims to assess the impact of SNS use on loneliness, that is the primary outcome of this study. The study is constituted of two stages, i.e. the baseline and the follow up. The experiment is structured into two treatment groups and a control group; the interventions are the attendance to a course on SNS use (T1) and lifestyle education and brain functioning (T2). The control group (C) is constituted of a waiting list. The study is part of the project "Aging in a networked society. Older people, social networks and well-being", funded by the Italian Fondazione Cariplo.

Conditions

  • Loneliness
  • Social Isolation

Interventions

OTHER

Facebook course

The intervention consists of the attendance to a course on Facebook and Social Networking Sites use

OTHER

Lifestyle Course

The intervention consists of the attendance to a course on lifestyle education and brain functioning in older people

Sponsors & Collaborators

  • Fondazione Golgi Cenci

    collaborator OTHER

  • University of Milano Bicocca

    lead OTHER

Principal Investigators

  • Emanuela Sala, PhD · Università degli Studi di Milano-Bicocca

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-14
Primary Completion
2020-07-31
Completion
2020-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04242628 on ClinicalTrials.gov